Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 

Abbott Laboratories : Abbott Introduces OneLab, a Novel Integrated Web-Based Software Platform to Manage the Vast Amounts of Information Flowing Through the Lab

07/11/2012| 06:05am US/Eastern
Recommend:
0

ABBOTT PARK, Ill., July 11, 2012 /PRNewswire/ -- As health care systems around the world face challenges such as labor shortages, increased regulation and budget constraints, they rely on technology to help manage the impact. To assist in addressing these challenges, today Abbott (NYSE: ABT) announced OneLab, a new, Web-based, integrated laboratory informatics solution. OneLab is a highly-configurable platform that allows labs of any size to standardize processes across multiple locations and automate routine procedures such as sample management and tracking, as well as test result review and approval. This new information management capability can improve efficiency and productivity while reducing errors, which is important for patient safety.

"The essence of diagnostic testing is accurate medical information and, most importantly, the ability to provide it to clinicians when, where and how they need it," said Brian Blaser, executive vice president, Diagnostics Products, Abbott. "Our customers are processing large volumes of tests for physicians. OneLab allows labs to address these operational challenges without sacrificing quality or efficiency."

Informatics refers to the processing, management and retrieval of information, which is critical for making clinical decisions. In the laboratory, clinical decision-making requires access to timely and accurate information. OneLab unites most of a laboratory's information and decision tools into one easy-to-use system, allowing labs to manage data with a single user interface. The solution is comprised of three applications: Smart Center, Inventory Manager, and Decision Center.

    --  Smart Center is a Web-based laboratory process management and control
        application and the heart of the OneLab platform. It provides robust
        connectivity to instruments and a single point for consolidated
        information. The built-in functionality enables the automation of
        complex clinical laboratory protocols, leading to greater productivity
        and standardization of best practices. Together, all these capabilities
        and benefits support the quality of care.
    --  Inventory Manager is an inventory tracking and order management system
        that utilizes Radio Frequency Identification (RFID). Inventory Manager
        provides an automated solution to improve the accuracy of order entry,
        inventory count and usage, while reducing labor required to track
        supplies.
    --  Decision Center is a business performance application that utilizes
        sophisticated tools to bring together data from different sources to
        optimize decision-making. Using advanced database technology, data can
        be integrated from multiple sources and quickly structured into visually
        accessible formats.

"No matter where they are located, laboratories around the world all share common challenges - increasing test loads, staff shortages and mounting pressure to do more with less while improving quality," said Ulf Oesinghaus, deputy pharmacy manager, laboratory director of strategic purchasing, University of Medicine Gottingen, Germany.

"To address challenges posed by cost pressures and staff shortages, labs want informatics solutions that help them expedite test result processing and transmit clinical information clearly and rapidly to physicians. A reliable and easy-to-use informatics system can achieve productivity, clear communication between the laboratory and clinicians, and cost and labor savings to improve the laboratory's efficiency and performance within any health care setting," he said.

Abbott introduced OneLab in Australia, Belgium, France, Germany, Italy, Ireland, Luxembourg, The Netherlands, New Zealand, United Kingdom, and Spain. Additional launches, including the United States, are scheduled for later in 2012 and 2013.

About Abbott Diagnostics

Abbott is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics. With more than 22,000 customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, bedside testing, cost effectiveness and flexibility. Abbott has helped transform the practice of medical diagnosis from an art to a science through the company's commitment to improving patient care and lowering costs.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries.

Abbott's information and news releases are available on the company's Web site at www.abbott.com.

SOURCE Abbott

Recommend :
0
Partner Area
React to this article
 
Latest news on ABBOTT LABORATORIES
5d agoDJAbbVie, Alvine Pharma to Collaborate on Investigational Drug for Celiac Disea..
05/10DJAbbVie Chief Scientific Officer John Leonard to Retire
05/09 ABBOTT LABORATORIES: Abbott Announces CE Mark for Test to Aid Doctors with Diag..
05/08 ABBOTT LABORATORIES: Abbott to Present at UBS Global Healthcare Conference
04/30DJBOND REPORT: Apple Prices $17 Bln Bond Deal To Strong Demand
04/30DJBOND REPORT: Apple Launches $17 Bln Bond Deal
04/30DJBOND REPORT: Apple Launches $17 Bln Bond Deal
04/30DJBOND REPORT: Apple Launches $17 Bln Bond Deal
04/30DJBOND REPORT: Apple Sees High Demand For Bond Offering
04/30DJAuction of Brazilian Drug Company Ache Stalls on Differences Among Family Own..
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.